Comments to FDA: Remote Regulatory Assessments Draft Guidance

Share page:
Docket Number:
FDA-2022-D-0810

CHPA appreciates the opportunity to provide comments on FDA Remote Regulatory Assessments Draft Guidance.

Related Posts

CHPA Statement on Valisure Citizen Petition